The Latest Breaking News from Food and Drug Administration

The Lucira COVID-19 and Flu Home Test is a single-use test, which can be purchased without a prescription.

A coalition of state attorneys general is suing the Food and Drug Administration over its regulation of mifepristone. NPR's Michel Martin speaks with Washington state Attorney General Bob Ferguson.

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine.

The Food and Drug Administration has approved the first combination test for flu and COVID-19 that can be used at home, giving consumers an easy way to determine if a runny nose is caused by either disease

The Food and Drug Administration has approved the first combination test for flu and COVID-19 that can be used at home, giving consumers an easy way to determine if a runny nose is caused by either disease

The Food and Drug Administration on Friday announced a series of actions meant to improve its oversight of tobacco and nicotine products, most notably e-cigarettes.

The suit comes as a federal judge in another case is considering whether to overturn FDA approval of the same drug, mifepristone.

The Food and Drug Administration is pledging a reset in the agency’s tobacco program

The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs.

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation